Coffee, caffeine‐related genes, and Parkinson's disease: A case–control study
Identifieur interne : 002937 ( Main/Exploration ); précédent : 002936; suivant : 002938Coffee, caffeine‐related genes, and Parkinson's disease: A case–control study
Auteurs : Maurizio F. Facheris [États-Unis] ; Nicole K. Schneider [États-Unis] ; Timothy G. Lesnick [États-Unis] ; Mariza De Andrade [États-Unis] ; Julie M. Cunningham [États-Unis] ; Walter A. Rocca [États-Unis] ; Demetrius M. Maraganore [États-Unis]Source :
- Movement Disorders [ 0885-3185 ] ; 2008-10-30.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
- Adult, Aged, Aged, 80 and over, Caffeine, Caffeine (administration & dosage), Case control study, Case-Control Studies, Coffee, Cytochrome P-450 CYP1A2 (genetics), DNA Mutational Analysis (methods), Drinking Behavior (drug effects), Female, Genetic Linkage, Genetic Predisposition to Disease (genetics), Humans, Male, Middle Aged, Nervous system diseases, Parkinson Disease (epidemiology), Parkinson Disease (genetics), Parkinson Disease (prevention & control), Parkinson disease, Parkinson's disease, Polymorphism, Single Nucleotide, Receptor, Adenosine A2A (genetics), Reproducibility of Results, Retrospective Studies, Risk Factors, coffee, genes.
- MESH :
- chemical , administration & dosage : Caffeine.
- chemical , genetics : Cytochrome P-450 CYP1A2, Receptor, Adenosine A2A.
- drug effects : Drinking Behavior.
- epidemiology : Parkinson Disease.
- genetics : Genetic Predisposition to Disease, Parkinson Disease.
- methods : DNA Mutational Analysis.
- prevention & control : Parkinson Disease.
- Adult, Aged, Aged, 80 and over, Case-Control Studies, Coffee, Female, Genetic Linkage, Humans, Male, Middle Aged, Polymorphism, Single Nucleotide, Reproducibility of Results, Retrospective Studies, Risk Factors.
Abstract
An inverse association between coffee and Parkinson's disease (PD) has been reported. However, it remains uncertain why some but not all coffee drinkers are less susceptible to PD. We considered the possibility of a pharmacogenetic effect. In our study, we included 1,208 subjects (446 case‐unaffected sibling pairs and 158 case‐unrelated control pairs) recruited from an ongoing study of the molecular epidemiology of PD in the Upper Midwest (USA). We collected information on lifetime coffee drinking and we studied two genes: ADORA2A, which encodes the major receptor activity of caffeine in the brain (variants rs5751876 and rs3032740), and CYP1A2, which encodes the major rate‐limiting step of caffeine metabolism (variants rs35694136 and rs762551). We did not observe significant associations of coffee drinking or of the genetic variants with PD susceptibility, either independently or jointly, in the sample overall and in most strata. Our study neither supports the hypothesis that coffee protects against PD nor provides evidence for a pharmacogenetic effect. © 2008 Movement Disorder Society
Url:
- https://api.istex.fr/document/59393BEDCB3F50FE8F4A5DCF1542AC8DCAF61CBA/fulltext/pdf
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554698
DOI: 10.1002/mds.22247
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001340
- to stream Istex, to step Curation: 001340
- to stream Istex, to step Checkpoint: 001494
- to stream Pmc, to step Corpus: 000203
- to stream Pmc, to step Curation: 000203
- to stream Pmc, to step Checkpoint: 000450
- to stream PubMed, to step Corpus: 002077
- to stream PubMed, to step Curation: 002077
- to stream PubMed, to step Checkpoint: 002377
- to stream Ncbi, to step Merge: 002286
- to stream Ncbi, to step Curation: 002286
- to stream Ncbi, to step Checkpoint: 002286
- to stream Main, to step Merge: 003516
- to stream PascalFrancis, to step Corpus: 001057
- to stream PascalFrancis, to step Curation: 001C62
- to stream PascalFrancis, to step Checkpoint: 001320
- to stream Main, to step Merge: 003928
- to stream Main, to step Curation: 002937
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Coffee, caffeine‐related genes, and Parkinson's disease: A case–control study</title><author><name sortKey="Facheris, Maurizio F" sort="Facheris, Maurizio F" uniqKey="Facheris M" first="Maurizio F." last="Facheris">Maurizio F. Facheris</name></author><author><name sortKey="Schneider, Nicole K" sort="Schneider, Nicole K" uniqKey="Schneider N" first="Nicole K." last="Schneider">Nicole K. Schneider</name></author><author><name sortKey="Lesnick, Timothy G" sort="Lesnick, Timothy G" uniqKey="Lesnick T" first="Timothy G." last="Lesnick">Timothy G. Lesnick</name></author><author><name sortKey="De Andrade, Mariza" sort="De Andrade, Mariza" uniqKey="De Andrade M" first="Mariza" last="De Andrade">Mariza De Andrade</name></author><author><name sortKey="Cunningham, Julie M" sort="Cunningham, Julie M" uniqKey="Cunningham J" first="Julie M." last="Cunningham">Julie M. Cunningham</name></author><author><name sortKey="Rocca, Walter A" sort="Rocca, Walter A" uniqKey="Rocca W" first="Walter A." last="Rocca">Walter A. Rocca</name></author><author><name sortKey="Maraganore, Demetrius M" sort="Maraganore, Demetrius M" uniqKey="Maraganore D" first="Demetrius M." last="Maraganore">Demetrius M. Maraganore</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:59393BEDCB3F50FE8F4A5DCF1542AC8DCAF61CBA</idno><date when="2008" year="2008">2008</date><idno type="doi">10.1002/mds.22247</idno><idno type="url">https://api.istex.fr/document/59393BEDCB3F50FE8F4A5DCF1542AC8DCAF61CBA/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001340</idno><idno type="wicri:Area/Istex/Curation">001340</idno><idno type="wicri:Area/Istex/Checkpoint">001494</idno><idno type="wicri:doubleKey">0885-3185:2008:Facheris M:coffee:caffeine:related</idno><idno type="wicri:source">PMC</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554698</idno><idno type="RBID">PMC:4554698</idno><idno type="wicri:Area/Pmc/Corpus">000203</idno><idno type="wicri:Area/Pmc/Curation">000203</idno><idno type="wicri:Area/Pmc/Checkpoint">000450</idno><idno type="wicri:source">PubMed</idno><idno type="wicri:Area/PubMed/Corpus">002077</idno><idno type="wicri:Area/PubMed/Curation">002077</idno><idno type="wicri:Area/PubMed/Checkpoint">002377</idno><idno type="wicri:Area/Ncbi/Merge">002286</idno><idno type="wicri:Area/Ncbi/Curation">002286</idno><idno type="wicri:Area/Ncbi/Checkpoint">002286</idno><idno type="wicri:doubleKey">0885-3185:2008:Facheris M:coffee:caffeine:related</idno><idno type="wicri:Area/Main/Merge">003516</idno><idno type="wicri:source">INIST</idno><idno type="RBID">Pascal:08-0536685</idno><idno type="wicri:Area/PascalFrancis/Corpus">001057</idno><idno type="wicri:Area/PascalFrancis/Curation">001C62</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">001320</idno><idno type="wicri:doubleKey">0885-3185:2008:Facheris M:coffee:caffeine:related</idno><idno type="wicri:Area/Main/Merge">003928</idno><idno type="wicri:Area/Main/Curation">002937</idno><idno type="wicri:Area/Main/Exploration">002937</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Coffee, caffeine‐related genes, and Parkinson's disease: A case–control study</title><author><name sortKey="Facheris, Maurizio F" sort="Facheris, Maurizio F" uniqKey="Facheris M" first="Maurizio F." last="Facheris">Maurizio F. Facheris</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, Mayo Clinic, Rochester, Minnesota</wicri:regionArea><placeName><region type="state">Minnesota</region></placeName></affiliation></author><author><name sortKey="Schneider, Nicole K" sort="Schneider, Nicole K" uniqKey="Schneider N" first="Nicole K." last="Schneider">Nicole K. Schneider</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota</wicri:regionArea><placeName><region type="state">Minnesota</region></placeName></affiliation></author><author><name sortKey="Lesnick, Timothy G" sort="Lesnick, Timothy G" uniqKey="Lesnick T" first="Timothy G." last="Lesnick">Timothy G. Lesnick</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota</wicri:regionArea><placeName><region type="state">Minnesota</region></placeName></affiliation></author><author><name sortKey="De Andrade, Mariza" sort="De Andrade, Mariza" uniqKey="De Andrade M" first="Mariza" last="De Andrade">Mariza De Andrade</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota</wicri:regionArea><placeName><region type="state">Minnesota</region></placeName></affiliation></author><author><name sortKey="Cunningham, Julie M" sort="Cunningham, Julie M" uniqKey="Cunningham J" first="Julie M." last="Cunningham">Julie M. Cunningham</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Laboratory Medicine, Mayo Clinic, Rochester, Minnesota</wicri:regionArea><placeName><region type="state">Minnesota</region></placeName></affiliation></author><author><name sortKey="Rocca, Walter A" sort="Rocca, Walter A" uniqKey="Rocca W" first="Walter A." last="Rocca">Walter A. Rocca</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, Mayo Clinic, Rochester, Minnesota</wicri:regionArea><placeName><region type="state">Minnesota</region></placeName></affiliation><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota</wicri:regionArea><placeName><region type="state">Minnesota</region></placeName></affiliation></author><author><name sortKey="Maraganore, Demetrius M" sort="Maraganore, Demetrius M" uniqKey="Maraganore D" first="Demetrius M." last="Maraganore">Demetrius M. Maraganore</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, Mayo Clinic, Rochester, Minnesota</wicri:regionArea><placeName><region type="state">Minnesota</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2008-10-30">2008-10-30</date><biblScope unit="vol">23</biblScope><biblScope unit="issue">14</biblScope><biblScope unit="page" from="2033">2033</biblScope><biblScope unit="page" to="2040">2040</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">59393BEDCB3F50FE8F4A5DCF1542AC8DCAF61CBA</idno><idno type="DOI">10.1002/mds.22247</idno><idno type="ArticleID">MDS22247</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Caffeine</term><term>Caffeine (administration & dosage)</term><term>Case control study</term><term>Case-Control Studies</term><term>Coffee</term><term>Cytochrome P-450 CYP1A2 (genetics)</term><term>DNA Mutational Analysis (methods)</term><term>Drinking Behavior (drug effects)</term><term>Female</term><term>Genetic Linkage</term><term>Genetic Predisposition to Disease (genetics)</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Nervous system diseases</term><term>Parkinson Disease (epidemiology)</term><term>Parkinson Disease (genetics)</term><term>Parkinson Disease (prevention & control)</term><term>Parkinson disease</term><term>Parkinson's disease</term><term>Polymorphism, Single Nucleotide</term><term>Receptor, Adenosine A2A (genetics)</term><term>Reproducibility of Results</term><term>Retrospective Studies</term><term>Risk Factors</term><term>coffee</term><term>genes</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Caffeine</term></keywords><keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Cytochrome P-450 CYP1A2</term><term>Receptor, Adenosine A2A</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Drinking Behavior</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Genetic Predisposition to Disease</term><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>DNA Mutational Analysis</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Case-Control Studies</term><term>Coffee</term><term>Female</term><term>Genetic Linkage</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Polymorphism, Single Nucleotide</term><term>Reproducibility of Results</term><term>Retrospective Studies</term><term>Risk Factors</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Caféine</term><term>Etude cas témoin</term><term>Maladie de Parkinson</term><term>Pathologie du système nerveux</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">An inverse association between coffee and Parkinson's disease (PD) has been reported. However, it remains uncertain why some but not all coffee drinkers are less susceptible to PD. We considered the possibility of a pharmacogenetic effect. In our study, we included 1,208 subjects (446 case‐unaffected sibling pairs and 158 case‐unrelated control pairs) recruited from an ongoing study of the molecular epidemiology of PD in the Upper Midwest (USA). We collected information on lifetime coffee drinking and we studied two genes: ADORA2A, which encodes the major receptor activity of caffeine in the brain (variants rs5751876 and rs3032740), and CYP1A2, which encodes the major rate‐limiting step of caffeine metabolism (variants rs35694136 and rs762551). We did not observe significant associations of coffee drinking or of the genetic variants with PD susceptibility, either independently or jointly, in the sample overall and in most strata. Our study neither supports the hypothesis that coffee protects against PD nor provides evidence for a pharmacogenetic effect. © 2008 Movement Disorder Society</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Minnesota</li></region></list><tree><country name="États-Unis"><region name="Minnesota"><name sortKey="Facheris, Maurizio F" sort="Facheris, Maurizio F" uniqKey="Facheris M" first="Maurizio F." last="Facheris">Maurizio F. Facheris</name></region><name sortKey="Cunningham, Julie M" sort="Cunningham, Julie M" uniqKey="Cunningham J" first="Julie M." last="Cunningham">Julie M. Cunningham</name><name sortKey="De Andrade, Mariza" sort="De Andrade, Mariza" uniqKey="De Andrade M" first="Mariza" last="De Andrade">Mariza De Andrade</name><name sortKey="Lesnick, Timothy G" sort="Lesnick, Timothy G" uniqKey="Lesnick T" first="Timothy G." last="Lesnick">Timothy G. Lesnick</name><name sortKey="Maraganore, Demetrius M" sort="Maraganore, Demetrius M" uniqKey="Maraganore D" first="Demetrius M." last="Maraganore">Demetrius M. Maraganore</name><name sortKey="Rocca, Walter A" sort="Rocca, Walter A" uniqKey="Rocca W" first="Walter A." last="Rocca">Walter A. Rocca</name><name sortKey="Rocca, Walter A" sort="Rocca, Walter A" uniqKey="Rocca W" first="Walter A." last="Rocca">Walter A. Rocca</name><name sortKey="Schneider, Nicole K" sort="Schneider, Nicole K" uniqKey="Schneider N" first="Nicole K." last="Schneider">Nicole K. Schneider</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002937 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002937 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:59393BEDCB3F50FE8F4A5DCF1542AC8DCAF61CBA
|texte= Coffee, caffeine‐related genes, and Parkinson's disease: A case–control study
}}
| This area was generated with Dilib version V0.6.23. |  |